New Results
Cdt1 inhibits CMG helicase in early S phase to separate origin licensing from DNA synthesis
View ORCID ProfileNalin Ratnayeke, View ORCID ProfileMingyu Chung, View ORCID ProfileTobias Meyer
doi: https://doi.org/10.1101/2021.07.06.451311
Nalin Ratnayeke
1Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA 94305, USA
2Department of Cell and Developmental Biology, Weill Cornell Medical College, New York, NY 10065, USA
Mingyu Chung
1Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA 94305, USA
Tobias Meyer
1Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA 94305, USA
2Department of Cell and Developmental Biology, Weill Cornell Medical College, New York, NY 10065, USA
3Lead Contact
Posted July 06, 2021.
Cdt1 inhibits CMG helicase in early S phase to separate origin licensing from DNA synthesis
Nalin Ratnayeke, Mingyu Chung, Tobias Meyer
bioRxiv 2021.07.06.451311; doi: https://doi.org/10.1101/2021.07.06.451311
Subject Area
Subject Areas
- Biochemistry (11703)
- Bioengineering (8722)
- Bioinformatics (29127)
- Biophysics (14932)
- Cancer Biology (12048)
- Cell Biology (17359)
- Clinical Trials (138)
- Developmental Biology (9406)
- Ecology (14143)
- Epidemiology (2067)
- Evolutionary Biology (18268)
- Genetics (12220)
- Genomics (16766)
- Immunology (11841)
- Microbiology (28005)
- Molecular Biology (11552)
- Neuroscience (60808)
- Paleontology (450)
- Pathology (1864)
- Pharmacology and Toxicology (3231)
- Physiology (4939)
- Plant Biology (10384)
- Synthetic Biology (2877)
- Systems Biology (7333)
- Zoology (1642)